Gero Alternatives & Competitors
12 companies similar to Gero — AI-driven drug discovery company focused on therapies targeting age-related dise...
Companies similar to Gero
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
Elixir Pharmaceuticals
Pioneering the future of metabolic disease treatment by harnessing genetic interactions to...
Standigm
The workflow AI drug discovery company
Rival Readout
Competing with Gero? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Aria Pharmaceuticals
Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and develop...
Moonwalk Biosciences
Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and ep...
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
Enable Medicine
Spatial and multimodal insights powered by AI for your next therapeutic breakthrough.
RiboNova, Inc.
Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset...
Lento Bio
Restoring Tissue Flexibility and Function in Chronic Diseases of Aging
iLOF
Using AI and Photonics to enable a new era of personalized, precision medicine.
Abarceo Pharma AB
Developing the first disease modifying and durable treatment for type 2 and type 1 diabete...
About Gero
Gero, founded in 2018, is an AI-driven drug discovery company focused on therapies targeting age-related diseases. The company is headquartered in the United States and operates at the intersection of AI, Biotechnology, Insurtech, and Pharmaceutical industries. At its core, Gero aims to eliminate age-related diseases b...
Developing drugs targeting aging, AI models for disease progression, Collaborative drug discovery with pharma companies
Pharmaceutical companies, Healthcare researchers, Investors interested in biotechnology, Aging and longevity research institutions
AI Drug Discovery, Age-related Diseases, Preclinical Stage, Disease Phenotypes, Real-world Human Data, Genetic Study, Novel Target Discovery, Chronic Diseases, Longevity Research, Marker Identification, Drug Development, MHealth, Digital Health, Biological Age
B2B, Platform, SaaS
Licensing, Project Based, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Gero: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Gero on 15 Jun 2026. The 12 companies listed here were last checked between 21 Jun 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.